Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China · Delayed Price · Currency is CNY 9.35
-0.05 (-0.53%)
Jun 9, 2026, 3:04 PM CST
SHE:002399 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 12,413 | 15,735 | 14,152 | 15,345 | 17,090 | 22,787 | |
Market Cap Growth | -15.54% | 11.19% | -7.78% | -10.21% | -25.00% | -3.74% |
Enterprise Value | 12,220 | 15,791 | 15,456 | 19,083 | 19,992 | 24,281 |
Last Close Price | 9.35 | 11.79 | 10.47 | 11.49 | 12.47 | 16.56 |
PE Ratio | 36.06 | 45.02 | 21.88 | - | 23.49 | 94.63 |
Forward PE | 16.12 | 18.64 | 20.66 | 24.06 | 14.64 | 31.09 |
PS Ratio | 2.29 | 2.87 | 2.68 | 2.83 | 2.39 | 3.58 |
PB Ratio | 1.02 | 1.30 | 1.16 | 1.28 | 1.38 | 1.98 |
P/TBV Ratio | 1.29 | 1.67 | 1.51 | 1.66 | 1.81 | 2.62 |
P/FCF Ratio | 8.59 | 9.89 | 7.11 | - | - | - |
P/OCF Ratio | 8.03 | 9.19 | 6.45 | 38.53 | - | - |
EV/Sales Ratio | 2.26 | 2.88 | 2.93 | 3.51 | 2.79 | 3.82 |
EV/EBITDA Ratio | 12.57 | 17.79 | 15.00 | 180.70 | 15.71 | 22.01 |
EV/EBIT Ratio | 19.97 | 27.84 | 21.09 | - | 20.02 | 29.13 |
EV/FCF Ratio | 8.46 | 9.92 | 7.76 | - | - | - |
Debt / Equity Ratio | 0.27 | 0.25 | 0.29 | 0.46 | 0.52 | 0.49 |
Debt / EBITDA Ratio | 3.36 | 3.23 | 3.33 | 38.64 | 4.95 | 4.98 |
Debt / FCF Ratio | 2.26 | 1.87 | 1.78 | - | - | - |
Net Debt / Equity Ratio | -0.02 | 0.01 | 0.08 | 0.27 | 0.24 | 0.15 |
Net Debt / EBITDA Ratio | -0.26 | 0.16 | 0.96 | 30.08 | 2.37 | 1.57 |
Net Debt / FCF Ratio | -0.17 | 0.09 | 0.50 | -81.01 | -3.08 | -8.62 |
Asset Turnover | 0.31 | 0.32 | 0.29 | 0.27 | 0.36 | 0.33 |
Inventory Turnover | 0.80 | 0.77 | 0.59 | 0.67 | 0.84 | 1.11 |
Quick Ratio | 1.10 | 1.14 | 1.10 | 0.76 | 0.94 | 1.19 |
Current Ratio | 2.15 | 2.32 | 2.60 | 2.13 | 2.22 | 2.25 |
Return on Equity (ROE) | 3.04% | 2.82% | 5.17% | -6.58% | 5.97% | 2.01% |
Return on Assets (ROA) | 2.21% | 2.09% | 2.51% | -0.68% | 3.13% | 2.73% |
Return on Invested Capital (ROIC) | 4.38% | 3.80% | 4.45% | -1.42% | 6.00% | 6.18% |
Return on Capital Employed (ROCE) | 4.90% | 4.50% | 5.40% | -1.50% | 6.60% | 5.80% |
Earnings Yield | 3.07% | 2.22% | 4.57% | -5.10% | 4.26% | 1.06% |
FCF Yield | 11.64% | 10.12% | 14.07% | -0.26% | -5.73% | -0.88% |
Dividend Yield | 1.54% | 1.23% | 2.39% | - | 0.80% | 0.21% |
Payout Ratio | 110.79% | 123.27% | 24.72% | - | 34.51% | 171.31% |
Buyback Yield / Dilution | 0.01% | 0.00% | 0.72% | -0.67% | -0.05% | -8.42% |
Total Shareholder Return | 1.52% | 1.23% | 3.11% | -0.67% | 0.75% | -8.21% |